Gilead Sciences
GILD
#133
Rank
$104.54 B
Marketcap
$83.35
Share price
-0.45%
Change (1 day)
21.36%
Change (1 year)

P/E ratio for Gilead Sciences (GILD)

P/E ratio as of January 2023 (TTM): 31.3

According to Gilead Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.3346. At the end of 2021 the company had a P/E ratio of 14.7.

P/E ratio history for Gilead Sciences from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202114.7-97.48%
20205833701.51%
201915.32.96%
201814.9-26.45%
201720.2184.87%
20167.10-13.23%
20158.19-30.86%
201411.8-68.31%
201337.473.46%
201221.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.2-29.00%๐Ÿ‡บ๐Ÿ‡ธ USA
8.20-73.83%๐Ÿ‡บ๐Ÿ‡ธ USA
19.2-38.71%๐Ÿ‡บ๐Ÿ‡ธ USA
52.5 67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
20.1-35.97%๐Ÿ‡บ๐Ÿ‡ธ USA
14.5-53.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-7.96-125.41%๐Ÿ‡บ๐Ÿ‡ธ USA
25.0-20.28%๐Ÿ‡บ๐Ÿ‡ธ USA
17.6-43.85%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.